AstraZeneca To Supply 400M Doses of Vaccines to IVA by the End of 2020

 AstraZeneca To Supply 400M Doses of Vaccines to IVA by the End of 2020

AstraZeneca To Supply 400M Doses of Vaccines to IVA by the End of 2020

Shots:

  • AstraZeneca has signed an agreement with EU’s IVA, spearheaded by Germany, France, Italy, and the Netherlands, to supply up to 400M doses of the University of Oxford’s AZD1222, with deliveries starting by the end of 2020
  • The collaboration allows IVA to accelerate the supply of the vaccine and to provide equitable access to all participating countries across the EU
  • Additionally, AstraZeneca had signed a similar kind of agreement with US, UK, CEPI, GAVI for $700M doses, and collaborated with SII for 1B doses. Last month, Oxford University has initiated P- II/III UK trial of AZD1222 in ~10,000 adult volunteers

Click here to read full press release/ article | Ref: AstraZeneca | Image: Barrons

Related News: AstraZeneca Signs an Agreement with Serum Institute to Supply 1B Doses of Oxford University’s COVID-19 Vaccine

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post